37
Participants
Start Date
December 31, 2009
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
LOC-paclitaxel
"Phase I Starting Dose: 100 mg/m\^2 IV (intravenously) 1 hour infusion on Day 1, 8, 15, 22 and 29; and repeated every 42 days (6 weeks) per cycle.~Phase II Starting Dose: Maximum tolerated dose from Phase I."
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
American Regent, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER